ID   GNAI1_RAT               Reviewed;         354 AA.
AC   P10824; Q45QN2;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   25-APR-2018, entry version 184.
DE   RecName: Full=Guanine nucleotide-binding protein G(i) subunit alpha-1;
DE   AltName: Full=Adenylate cyclase-inhibiting G alpha protein;
GN   Name=Gnai1; Synonyms=Gnai-1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2820999;
RA   Jones D.T., Reed R.R.;
RT   "Molecular cloning of five GTP-binding protein cDNA species from rat
RT   olfactory neuroepithelium.";
RL   J. Biol. Chem. 262:14241-14249(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=SHR, and Wistar Kyoto;
RA   Jackson E.K., Zhu C.;
RT   "Genetic similarity between spontaneously hypertensive rats and
RT   Wistar-Kyoto rats in the coding regions of signal transduction
RT   proteins.";
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   INTERACTION WITH GPSM1.
RX   PubMed=11121039; DOI=10.1073/pnas.97.26.14364;
RA   de Vries L., Fischer T., Tronchere H., Brothers G.M., Strockbine B.,
RA   Siderovski D.P., Farquhar M.G.;
RT   "Activator of G protein signaling 3 is a guanine dissociation
RT   inhibitor for Galpha i subunits.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:14364-14369(2000).
RN   [4]
RP   INTERACTION WITH RGS12 AND RGS14.
RX   PubMed=11387333; DOI=10.1074/jbc.M103208200;
RA   Kimple R.J., De Vries L., Tronchere H., Behe C.I., Morris R.A.,
RA   Gist Farquhar M., Siderovski D.P.;
RT   "RGS12 and RGS14 GoLoco motifs are G alpha(i) interaction sites with
RT   guanine nucleotide dissociation inhibitor activity.";
RL   J. Biol. Chem. 276:29275-29281(2001).
RN   [5]
RP   FUNCTION, INTERACTION WITH RGS14, AND SUBCELLULAR LOCATION.
RX   PubMed=16870394; DOI=10.1016/j.cellsig.2006.06.002;
RA   Shu F.J., Ramineni S., Amyot W., Hepler J.R.;
RT   "Selective interactions between Gi alpha1 and Gi alpha3 and the
RT   GoLoco/GPR domain of RGS14 influence its dynamic subcellular
RT   localization.";
RL   Cell. Signal. 19:163-176(2007).
RN   [6]
RP   SUBCELLULAR LOCATION, INTERACTION WITH RGS14, AND MUTAGENESIS OF
RP   GLN-204.
RX   PubMed=17635935; DOI=10.1083/jcb.200604114;
RA   Cho H., Kehrl J.H.;
RT   "Localization of Gi alpha proteins in the centrosomes and at the
RT   midbody: implication for their role in cell division.";
RL   J. Cell Biol. 178:245-255(2007).
RN   [7]
RP   INTERACTION WITH RGS14 AND RIC8A, MUTAGENESIS OF ASN-149, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=21158412; DOI=10.1021/bi101910n;
RA   Vellano C.P., Shu F.J., Ramineni S., Yates C.K., Tall G.G.,
RA   Hepler J.R.;
RT   "Activation of the regulator of G protein signaling 14-Galphai1-GDP
RT   signaling complex is regulated by resistance to inhibitors of
RT   cholinesterase-8A.";
RL   Biochemistry 50:752-762(2011).
RN   [8]
RP   MYRISTOYLATION AT GLY-2, PALMITOYLATION AT CYS-3, AND MUTAGENESIS OF
RP   GLY-2 AND CYS-3.
RX   PubMed=26253820; DOI=10.1016/j.bbalip.2015.08.001;
RA   Alvarez R., Lopez D.J., Casas J., Llado V., Higuera M., Nagy T.,
RA   Barcelo M., Busquets X., Escriba P.V.;
RT   "G protein-membrane interactions I: Galphai1 myristoyl and palmitoyl
RT   modifications in protein-lipid interactions and its implications in
RT   membrane microdomain localization.";
RL   Biochim. Biophys. Acta 1851:1511-1520(2015).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) IN COMPLEX WITH GDP.
RX   PubMed=8073283; DOI=10.1126/science.8073283;
RA   Coleman D.E., Berghuis A.M., Lee E., Linder M.E., Gilman A.G.,
RA   Sprang S.R.;
RT   "Structures of active conformations of Gi alpha 1 and the mechanism of
RT   GTP hydrolysis.";
RL   Science 265:1405-1412(1994).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) IN COMPLEX WITH GNB1; GNG2 AND
RP   GDP, AND SUBUNIT.
RX   PubMed=8521505; DOI=10.1016/0092-8674(95)90220-1;
RA   Wall M.A., Coleman D.E., Lee E., Iniguez-Lluhi J.A., Posner B.A.,
RA   Gilman A.G., Sprang S.R.;
RT   "The structure of the G protein heterotrimer Gi alpha 1 beta 1 gamma
RT   2.";
RL   Cell 83:1047-1058(1995).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) IN COMPLEX WITH RGS4 AND GDP,
RP   AND INTERACTION WITH RGS4.
RX   PubMed=9108480; DOI=10.1016/S0092-8674(00)80204-4;
RA   Tesmer J.J.G., Berman D.M., Gilman A.G., Sprang S.R.;
RT   "Structure of RGS4 bound to AlF4-activated G(i alpha1): stabilization
RT   of the transition state for GTP hydrolysis.";
RL   Cell 89:251-261(1997).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) IN COMPLEX WITH GDP.
RX   PubMed=9772163; DOI=10.1021/bi9810306;
RA   Coleman D.E., Sprang S.R.;
RT   "Crystal structures of the G protein Gi alpha 1 complexed with GDP and
RT   Mg2+: a crystallographic titration experiment.";
RL   Biochemistry 37:14376-14385(1998).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 32-346 IN COMPLEX WITH GDP
RP   AND MAGNESIUM.
RX   PubMed=9705312; DOI=10.1074/jbc.273.34.21752;
RA   Posner B.A., Mixon M.B., Wall M.A., Sprang S.R., Gilman A.G.;
RT   "The A326S mutant of Gialpha1 as an approximation of the receptor-
RT   bound state.";
RL   J. Biol. Chem. 273:21752-21758(1998).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 1-348 OF MUTANT ALA-329 IN
RP   COMPLEXES WITH MAGNESIUM; GDP AND GTP ANALOG, FUNCTION, AND
RP   MUTAGENESIS OF GLN-204; THR-329 AND VAL-332.
RX   PubMed=19703466; DOI=10.1016/j.jmb.2009.08.043;
RA   Kapoor N., Menon S.T., Chauhan R., Sachdev P., Sakmar T.P.;
RT   "Structural evidence for a sequential release mechanism for activation
RT   of heterotrimeric G proteins.";
RL   J. Mol. Biol. 393:882-897(2009).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (1.55 ANGSTROMS) IN COMPLEXES WITH GDP AND GTP
RP   ANALOG, FUNCTION, SUBCELLULAR LOCATION, SUBUNIT, INTERACTION WITH GNB1
RP   AND GNG1, AND MUTAGENESIS OF GLU-43 AND LYS-345.
RX   PubMed=24596087; DOI=10.1074/jbc.M113.539064;
RA   Thaker T.M., Sarwar M., Preininger A.M., Hamm H.E., Iverson T.M.;
RT   "A transient interaction between the phosphate binding loop and switch
RT   I contributes to the allosteric network between receptor and
RT   nucleotide in Galphai1.";
RL   J. Biol. Chem. 289:11331-11341(2014).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF WILD-TYPE AND MUTANTS
RP   CYS-336 AND TYR-336 IN COMPLEXES WITH MAGNESIUM; GDP AND GTP ANALOG,
RP   FUNCTION, SUBUNIT, AND MUTAGENESIS OF PHE-189; PHE-191 AND PHE-336.
RX   PubMed=25037222; DOI=10.1074/jbc.M114.572875;
RA   Kaya A.I., Lokits A.D., Gilbert J.A., Iverson T.M., Meiler J.,
RA   Hamm H.E.;
RT   "A conserved phenylalanine as a relay between the alpha5 helix and the
RT   GDP binding region of heterotrimeric Gi protein alpha subunit.";
RL   J. Biol. Chem. 289:24475-24487(2014).
CC   -!- FUNCTION: Guanine nucleotide-binding proteins (G proteins)
CC       function as transducers downstream of G protein-coupled receptors
CC       (GPCRs) in numerous signaling cascades. The alpha chain contains
CC       the guanine nucleotide binding site and alternates between an
CC       active, GTP-bound state and an inactive, GDP-bound state.
CC       Signaling by an activated GPCR promotes GDP release and GTP
CC       binding (PubMed:19703466, PubMed:24596087, PubMed:25037222). The
CC       alpha subunit has a low GTPase activity that converts bound GTP to
CC       GDP, thereby terminating the signal (PubMed:21158412). Both GDP
CC       release and GTP hydrolysis are modulated by numerous regulatory
CC       proteins (PubMed:21158412). Signaling is mediated via effector
CC       proteins, such as adenylate cyclase. Inhibits adenylate cyclase
CC       activity, leading to decreased intracellular cAMP levels
CC       (PubMed:19703466). The inactive GDP-bound form prevents the
CC       association of RGS14 with centrosomes and is required for the
CC       translocation of RGS14 from the cytoplasm to the plasma membrane.
CC       Required for normal cytokinesis during mitosis (PubMed:16870394).
CC       Required for cortical dynein-dynactin complex recruitment during
CC       metaphase (By similarity). {ECO:0000250|UniProtKB:P63096,
CC       ECO:0000269|PubMed:16870394, ECO:0000269|PubMed:19703466,
CC       ECO:0000269|PubMed:21158412, ECO:0000269|PubMed:24596087,
CC       ECO:0000269|PubMed:25037222, ECO:0000305}.
CC   -!- SUBUNIT: Heterotrimeric G proteins are composed of 3 units; alpha,
CC       beta and gamma. The alpha chain contains the guanine nucleotide
CC       binding site (PubMed:8521505, PubMed:24596087, PubMed:25037222).
CC       Part of a spindle orientation complex at least composed of GNAI1,
CC       GPSM2 and NUMA1 (By similarity). Identified in complex with the
CC       beta subunit GNB1 and the gamma subunit GNG1 (PubMed:24596087).
CC       Identified in complex with the beta subunit GNB1 and the gamma
CC       subunit GNG2 (PubMed:8521505). GTP binding causes dissociation of
CC       the heterotrimer, liberating the individual subunits so that they
CC       can interact with downstream effector proteins. Interacts (GDP-
CC       bound form) with GPSM1; this inhibits guanine nucleotide exchange
CC       and GTP binding (PubMed:11121039). Interacts (GDP-bound form) with
CC       GPSM2 (via GoLoco domains); this inhibits guanine nucleotide
CC       exchange (By similarity). Interacts with RGS10; this strongly
CC       enhances GTP hydrolysis. Interacts with RGS1 and RGS16 (By
CC       similarity). Interacts with RGS4 (PubMed:9108480). Interacts with
CC       RGS12 (PubMed:11387333). Interacts (via active GTP- or inactive
CC       GDP-bound forms) with RGS14 (via RGS and GoLoco domains)
CC       (PubMed:11387333, PubMed:16870394, PubMed:17635935,
CC       PubMed:21158412). Interacts with RGS3, RGS6, RGS7, RGS8, RGS17,
CC       RGS18 and RGS20 (in vitro) (By similarity). Interacts (GDP-bound
CC       form) with RIC8A (via C-terminus) (PubMed:21158412).
CC       {ECO:0000250|UniProtKB:P63096, ECO:0000269|PubMed:11121039,
CC       ECO:0000269|PubMed:11387333, ECO:0000269|PubMed:16870394,
CC       ECO:0000269|PubMed:17635935, ECO:0000269|PubMed:21158412,
CC       ECO:0000269|PubMed:25037222, ECO:0000269|PubMed:8521505,
CC       ECO:0000269|PubMed:9108480}.
CC   -!- SUBCELLULAR LOCATION: Nucleus. Cytoplasm
CC       {ECO:0000269|PubMed:17635935}. Cell membrane
CC       {ECO:0000269|PubMed:17635935, ECO:0000269|PubMed:21158412};
CC       Peripheral membrane protein {ECO:0000305|PubMed:24596087,
CC       ECO:0000305|PubMed:25037222}; Cytoplasmic side {ECO:0000305}.
CC       Cytoplasm, cytoskeleton, microtubule organizing center, centrosome
CC       {ECO:0000269|PubMed:17635935}. Cytoplasm, cell cortex
CC       {ECO:0000250|UniProtKB:P63096}. Membrane
CC       {ECO:0000250|UniProtKB:P63096}; Lipid-anchor
CC       {ECO:0000250|UniProtKB:P63096}. Note=Localizes in the centrosomes
CC       of interphase and mitotic cells, but not in centrosomes during
CC       cytokinesis. Detected at the cleavage furrow or the midbody.
CC       Localized at the plasma membrane throughout mitosis. Colocalizes
CC       with RIC8A and RGS14 at the plasma membrane.
CC       {ECO:0000269|PubMed:21158412}.
CC   -!- PTM: Myristoylation at Gly-2 is required for membrane anchoring
CC       before palmitoylation. {ECO:0000269|PubMed:26253820}.
CC   -!- PTM: Palmitoylation at Cys-3 varies with membrane lipid
CC       composition. {ECO:0000269|PubMed:26253820}.
CC   -!- SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M17527; AAA40825.1; -; mRNA.
DR   EMBL; DQ120469; AAZ23808.1; -; mRNA.
DR   EMBL; DQ120470; AAZ23809.1; -; mRNA.
DR   PIR; A35377; A35377.
DR   PIR; C27423; RGRTI1.
DR   RefSeq; NP_037277.1; NM_013145.1.
DR   UniGene; Rn.11391; -.
DR   PDB; 1AGR; X-ray; 2.80 A; A/D=2-354.
DR   PDB; 1AS0; X-ray; 2.00 A; A=2-354.
DR   PDB; 1AS2; X-ray; 2.80 A; A=2-354.
DR   PDB; 1AS3; X-ray; 2.40 A; A=2-354.
DR   PDB; 1BH2; X-ray; 2.10 A; A=32-346.
DR   PDB; 1BOF; X-ray; 2.20 A; A=2-354.
DR   PDB; 1CIP; X-ray; 1.50 A; A=2-354.
DR   PDB; 1FQJ; X-ray; 2.02 A; A/D=220-299.
DR   PDB; 1FQK; X-ray; 2.30 A; A/C=220-299.
DR   PDB; 1GDD; X-ray; 2.20 A; A=2-354.
DR   PDB; 1GFI; X-ray; 2.20 A; A=2-354.
DR   PDB; 1GG2; X-ray; 2.40 A; A=2-354.
DR   PDB; 1GIA; X-ray; 2.00 A; A=2-354.
DR   PDB; 1GIL; X-ray; 2.30 A; A=2-354.
DR   PDB; 1GIT; X-ray; 2.60 A; A=2-354.
DR   PDB; 1GP2; X-ray; 2.30 A; A=2-354.
DR   PDB; 1SHZ; X-ray; 2.85 A; A/D=22-48, A/D=185-353.
DR   PDB; 1SVK; X-ray; 2.00 A; A=2-354.
DR   PDB; 1SVS; X-ray; 1.50 A; A=2-354.
DR   PDB; 2BCJ; X-ray; 3.06 A; Q=1-28.
DR   PDB; 2ZJY; X-ray; 2.80 A; A=1-354.
DR   PDB; 2ZJZ; X-ray; 2.60 A; A/B=1-354.
DR   PDB; 3AH8; X-ray; 2.90 A; A=2-28.
DR   PDB; 3D7M; X-ray; 2.90 A; A=1-354.
DR   PDB; 3FFA; X-ray; 2.30 A; A=1-354.
DR   PDB; 3FFB; X-ray; 2.57 A; A=1-354.
DR   PDB; 3V00; X-ray; 2.90 A; A/B/C=220-298.
DR   PDB; 4N0D; X-ray; 1.55 A; A=1-354.
DR   PDB; 4N0E; X-ray; 2.10 A; A=1-354.
DR   PDB; 4PAM; X-ray; 2.10 A; A=1-354.
DR   PDB; 4PAN; X-ray; 2.40 A; A=1-354.
DR   PDB; 4PAO; X-ray; 2.00 A; A=1-354.
DR   PDB; 4PAQ; X-ray; 2.00 A; A=1-354.
DR   PDB; 5KDL; X-ray; 2.67 A; A/B=1-354.
DR   PDB; 5KDO; X-ray; 1.90 A; A=1-354.
DR   PDBsum; 1AGR; -.
DR   PDBsum; 1AS0; -.
DR   PDBsum; 1AS2; -.
DR   PDBsum; 1AS3; -.
DR   PDBsum; 1BH2; -.
DR   PDBsum; 1BOF; -.
DR   PDBsum; 1CIP; -.
DR   PDBsum; 1FQJ; -.
DR   PDBsum; 1FQK; -.
DR   PDBsum; 1GDD; -.
DR   PDBsum; 1GFI; -.
DR   PDBsum; 1GG2; -.
DR   PDBsum; 1GIA; -.
DR   PDBsum; 1GIL; -.
DR   PDBsum; 1GIT; -.
DR   PDBsum; 1GP2; -.
DR   PDBsum; 1SHZ; -.
DR   PDBsum; 1SVK; -.
DR   PDBsum; 1SVS; -.
DR   PDBsum; 2BCJ; -.
DR   PDBsum; 2ZJY; -.
DR   PDBsum; 2ZJZ; -.
DR   PDBsum; 3AH8; -.
DR   PDBsum; 3D7M; -.
DR   PDBsum; 3FFA; -.
DR   PDBsum; 3FFB; -.
DR   PDBsum; 3V00; -.
DR   PDBsum; 4N0D; -.
DR   PDBsum; 4N0E; -.
DR   PDBsum; 4PAM; -.
DR   PDBsum; 4PAN; -.
DR   PDBsum; 4PAO; -.
DR   PDBsum; 4PAQ; -.
DR   PDBsum; 5KDL; -.
DR   PDBsum; 5KDO; -.
DR   ProteinModelPortal; P10824; -.
DR   SMR; P10824; -.
DR   BioGrid; 247715; 1.
DR   CORUM; P10824; -.
DR   DIP; DIP-6073N; -.
DR   IntAct; P10824; 2.
DR   MINT; P10824; -.
DR   iPTMnet; P10824; -.
DR   PhosphoSitePlus; P10824; -.
DR   SwissPalm; P10824; -.
DR   World-2DPAGE; 0004:P10824; -.
DR   PRIDE; P10824; -.
DR   Ensembl; ENSRNOT00000091004; ENSRNOP00000074036; ENSRNOG00000057096.
DR   GeneID; 25686; -.
DR   KEGG; rno:25686; -.
DR   CTD; 2770; -.
DR   RGD; 2713; Gnai1.
DR   GeneTree; ENSGT00760000118851; -.
DR   HOGENOM; HOG000038730; -.
DR   HOVERGEN; HBG063184; -.
DR   InParanoid; P10824; -.
DR   KO; K04630; -.
DR   OMA; RIAQTSY; -.
DR   OrthoDB; EOG091G0VUT; -.
DR   PhylomeDB; P10824; -.
DR   Reactome; R-RNO-112043; PLC beta mediated events.
DR   Reactome; R-RNO-170670; Adenylate cyclase inhibitory pathway.
DR   Reactome; R-RNO-202040; G-protein activation.
DR   Reactome; R-RNO-392170; ADP signalling through P2Y purinoceptor 12.
DR   Reactome; R-RNO-400042; Adrenaline,noradrenaline inhibits insulin secretion.
DR   Reactome; R-RNO-418594; G alpha (i) signalling events.
DR   Reactome; R-RNO-6814122; Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding.
DR   SABIO-RK; P10824; -.
DR   EvolutionaryTrace; P10824; -.
DR   PRO; PR:P10824; -.
DR   Proteomes; UP000002494; Chromosome 4.
DR   Bgee; ENSRNOG00000057096; -.
DR   GO; GO:0099738; C:cell cortex region; ISS:UniProtKB.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; ISO:RGD.
DR   GO; GO:0005834; C:heterotrimeric G-protein complex; TAS:RGD.
DR   GO; GO:0005622; C:intracellular; ISO:RGD.
DR   GO; GO:0005765; C:lysosomal membrane; ISO:RGD.
DR   GO; GO:0016020; C:membrane; IDA:RGD.
DR   GO; GO:0045121; C:membrane raft; IDA:RGD.
DR   GO; GO:0030496; C:midbody; ISS:UniProtKB.
DR   GO; GO:0005730; C:nucleolus; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0031683; F:G-protein beta/gamma-subunit complex binding; IBA:GO_Central.
DR   GO; GO:0001664; F:G-protein coupled receptor binding; IDA:UniProtKB.
DR   GO; GO:0031821; F:G-protein coupled serotonin receptor binding; IPI:RGD.
DR   GO; GO:0019003; F:GDP binding; IDA:UniProtKB.
DR   GO; GO:0005525; F:GTP binding; IDA:UniProtKB.
DR   GO; GO:0032794; F:GTPase activating protein binding; IDA:RGD.
DR   GO; GO:0003924; F:GTPase activity; IDA:UniProtKB.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0004871; F:signal transducer activity; IBA:GO_Central.
DR   GO; GO:0007188; P:adenylate cyclase-modulating G-protein coupled receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0051301; P:cell division; ISS:UniProtKB.
DR   GO; GO:1904322; P:cellular response to forskolin; IMP:UniProtKB.
DR   GO; GO:0007186; P:G-protein coupled receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0050805; P:negative regulation of synaptic transmission; IMP:RGD.
DR   GO; GO:1904778; P:positive regulation of protein localization to cell cortex; ISS:UniProtKB.
DR   GO; GO:0043949; P:regulation of cAMP-mediated signaling; IMP:UniProtKB.
DR   GO; GO:0060236; P:regulation of mitotic spindle organization; ISS:UniProtKB.
DR   CDD; cd00066; G-alpha; 1.
DR   Gene3D; 1.10.400.10; -; 1.
DR   InterPro; IPR001408; Gprotein_alpha_I.
DR   InterPro; IPR001019; Gprotein_alpha_su.
DR   InterPro; IPR011025; GproteinA_insert.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR10218; PTHR10218; 1.
DR   Pfam; PF00503; G-alpha; 1.
DR   PRINTS; PR00318; GPROTEINA.
DR   PRINTS; PR00441; GPROTEINAI.
DR   SMART; SM00275; G_alpha; 1.
DR   SUPFAM; SSF47895; SSF47895; 1.
DR   SUPFAM; SSF52540; SSF52540; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Cell cycle; Cell division; Cell membrane;
KW   Complete proteome; Cytoplasm; Cytoskeleton; GTP-binding; Lipoprotein;
KW   Magnesium; Membrane; Metal-binding; Mitosis; Myristate;
KW   Nucleotide-binding; Nucleus; Palmitate; Reference proteome;
KW   Transducer; Transport.
FT   INIT_MET      1      1       Removed. {ECO:0000269|PubMed:26253820}.
FT   CHAIN         2    354       Guanine nucleotide-binding protein G(i)
FT                                subunit alpha-1.
FT                                /FTId=PRO_0000203673.
FT   NP_BIND      43     48       GTP. {ECO:0000244|PDB:1AS0,
FT                                ECO:0000244|PDB:1BH2,
FT                                ECO:0000244|PDB:1GIA,
FT                                ECO:0000244|PDB:1GIL,
FT                                ECO:0000244|PDB:3FFA,
FT                                ECO:0000244|PDB:4N0D,
FT                                ECO:0000244|PDB:4PAO,
FT                                ECO:0000244|PDB:4PAQ}.
FT   NP_BIND     150    151       GTP. {ECO:0000244|PDB:1AS0,
FT                                ECO:0000244|PDB:1BH2,
FT                                ECO:0000244|PDB:1GIL,
FT                                ECO:0000244|PDB:4N0D}.
FT   NP_BIND     175    178       GTP. {ECO:0000244|PDB:1AS0,
FT                                ECO:0000244|PDB:1BH2,
FT                                ECO:0000244|PDB:1GIA,
FT                                ECO:0000244|PDB:1GIL,
FT                                ECO:0000244|PDB:3FFA,
FT                                ECO:0000244|PDB:4N0D,
FT                                ECO:0000244|PDB:4PAO,
FT                                ECO:0000244|PDB:4PAQ}.
FT   NP_BIND     200    204       GTP. {ECO:0000244|PDB:1AS0,
FT                                ECO:0000244|PDB:1BH2,
FT                                ECO:0000244|PDB:1GIA,
FT                                ECO:0000244|PDB:1GIL,
FT                                ECO:0000244|PDB:3FFA,
FT                                ECO:0000244|PDB:4N0D,
FT                                ECO:0000244|PDB:4PAO,
FT                                ECO:0000244|PDB:4PAQ}.
FT   NP_BIND     269    272       GTP. {ECO:0000244|PDB:1AS0,
FT                                ECO:0000244|PDB:1BH2,
FT                                ECO:0000244|PDB:1GIA,
FT                                ECO:0000244|PDB:1GIL,
FT                                ECO:0000244|PDB:3FFA,
FT                                ECO:0000244|PDB:4N0D,
FT                                ECO:0000244|PDB:4PAO,
FT                                ECO:0000244|PDB:4PAQ}.
FT   METAL        47     47       Magnesium. {ECO:0000244|PDB:1BH2,
FT                                ECO:0000244|PDB:4PAO,
FT                                ECO:0000269|PubMed:25037222,
FT                                ECO:0000269|PubMed:9705312}.
FT   METAL       181    181       Magnesium. {ECO:0000244|PDB:1BH2,
FT                                ECO:0000244|PDB:4PAO,
FT                                ECO:0000269|PubMed:19703466,
FT                                ECO:0000269|PubMed:25037222,
FT                                ECO:0000269|PubMed:9705312}.
FT   BINDING     326    326       GTP; via amide nitrogen.
FT                                {ECO:0000244|PDB:1AS0,
FT                                ECO:0000244|PDB:1GIA,
FT                                ECO:0000244|PDB:1GIL,
FT                                ECO:0000244|PDB:3FFA,
FT                                ECO:0000244|PDB:4N0D,
FT                                ECO:0000244|PDB:4PAO,
FT                                ECO:0000244|PDB:4PAQ}.
FT   LIPID         2      2       N-myristoyl glycine.
FT                                {ECO:0000269|PubMed:26253820}.
FT   LIPID         3      3       S-palmitoyl cysteine.
FT                                {ECO:0000269|PubMed:26253820}.
FT   MUTAGEN       2      2       G->A: Abolishes myristoylation and
FT                                palmitoylation.
FT                                {ECO:0000269|PubMed:26253820}.
FT   MUTAGEN       3      3       C->S: Abolishes palmitoylation.
FT                                {ECO:0000269|PubMed:26253820}.
FT   MUTAGEN      43     43       E->A: Mildly impairs receptor binding;
FT                                mildly decreases basal and receptor-
FT                                stimulated GDP exchange.
FT                                {ECO:0000269|PubMed:24596087}.
FT   MUTAGEN     149    149       N->I: Inhibits interaction with RGS14.
FT                                Does not inhibit interaction with RIC8A.
FT                                {ECO:0000269|PubMed:21158412}.
FT   MUTAGEN     189    189       F->Y: Increases basal GDP exchange rate;
FT                                no effect on receptor-stimulated GDP
FT                                exchange. {ECO:0000269|PubMed:25037222}.
FT   MUTAGEN     191    191       F->Y: No effect on basal GDP exchange
FT                                rate; mildly decreases receptor-
FT                                stimulated GDP exchange.
FT                                {ECO:0000269|PubMed:25037222}.
FT   MUTAGEN     204    204       Q->L: Expected to have lost GTPase
FT                                activity; inhibits the forskolin-mediated
FT                                increase of cellular cAMP levels. Does
FT                                not inhibit interaction with RGS14 at
FT                                centrosomes.
FT                                {ECO:0000269|PubMed:17635935,
FT                                ECO:0000269|PubMed:19703466}.
FT   MUTAGEN     329    329       T->A: Increases basal GDP exchange rate
FT                                and inhibits the forskolin-mediated
FT                                increase of cellular cAMP levels.
FT                                {ECO:0000269|PubMed:19703466}.
FT   MUTAGEN     332    332       V->A: Increases basal GDP exchange rate.
FT                                {ECO:0000269|PubMed:19703466}.
FT   MUTAGEN     336    336       F->A,C: Increases basal GDP exchange
FT                                rate; mildly decreases receptor-
FT                                stimulated GDP exchange.
FT                                {ECO:0000269|PubMed:25037222}.
FT   MUTAGEN     336    336       F->Y: Strongly increases basal GDP
FT                                exchange rate; mildly decreases receptor-
FT                                stimulated GDP exchange.
FT                                {ECO:0000269|PubMed:25037222}.
FT   MUTAGEN     345    345       K->L: Mildly impairs receptor binding;
FT                                mildly decreases basal and receptor-
FT                                stimulated GDP exchange.
FT                                {ECO:0000269|PubMed:24596087}.
FT   HELIX         8     31       {ECO:0000244|PDB:5KDO}.
FT   STRAND       33     39       {ECO:0000244|PDB:1CIP}.
FT   HELIX        46     57       {ECO:0000244|PDB:1CIP}.
FT   HELIX        63     68       {ECO:0000244|PDB:1CIP}.
FT   HELIX        70     91       {ECO:0000244|PDB:1CIP}.
FT   HELIX       100    110       {ECO:0000244|PDB:1CIP}.
FT   HELIX       111    116       {ECO:0000244|PDB:1CIP}.
FT   HELIX       121    132       {ECO:0000244|PDB:1CIP}.
FT   HELIX       134    140       {ECO:0000244|PDB:1CIP}.
FT   HELIX       141    145       {ECO:0000244|PDB:1CIP}.
FT   HELIX       152    156       {ECO:0000244|PDB:1CIP}.
FT   HELIX       159    162       {ECO:0000244|PDB:1CIP}.
FT   STRAND      164    166       {ECO:0000244|PDB:2ZJY}.
FT   HELIX       171    175       {ECO:0000244|PDB:1CIP}.
FT   STRAND      183    191       {ECO:0000244|PDB:1CIP}.
FT   STRAND      194    201       {ECO:0000244|PDB:1CIP}.
FT   HELIX       205    214       {ECO:0000244|PDB:1CIP}.
FT   STRAND      219    226       {ECO:0000244|PDB:1CIP}.
FT   HELIX       227    231       {ECO:0000244|PDB:1CIP}.
FT   STRAND      237    241       {ECO:0000244|PDB:1CIP}.
FT   HELIX       242    254       {ECO:0000244|PDB:1CIP}.
FT   HELIX       257    259       {ECO:0000244|PDB:1CIP}.
FT   STRAND      262    269       {ECO:0000244|PDB:1CIP}.
FT   HELIX       271    278       {ECO:0000244|PDB:1CIP}.
FT   HELIX       283    285       {ECO:0000244|PDB:1CIP}.
FT   HELIX       296    308       {ECO:0000244|PDB:1CIP}.
FT   TURN        314    316       {ECO:0000244|PDB:1CIP}.
FT   STRAND      319    323       {ECO:0000244|PDB:1CIP}.
FT   HELIX       329    346       {ECO:0000244|PDB:1CIP}.
FT   HELIX       348    350       {ECO:0000244|PDB:4N0E}.
SQ   SEQUENCE   354 AA;  40345 MW;  99E9D11B485C2DE3 CRC64;
     MGCTLSAEDK AAVERSKMID RNLREDGEKA AREVKLLLLG AGESGKSTIV KQMKIIHEAG
     YSEEECKQYK AVVYSNTIQS IIAIIRAMGR LKIDFGDAAR ADDARQLFVL AGAAEEGFMT
     AELAGVIKRL WKDSGVQACF NRSREYQLND SAAYYLNDLD RIAQPNYIPT QQDVLRTRVK
     TTGIVETHFT FKDLHFKMFD VGGQRSERKK WIHCFEGVTA IIFCVALSDY DLVLAEDEEM
     NRMHESMKLF DSICNNKWFT DTSIILFLNK KDLFEEKIKK SPLTICYPEY AGSNTYEEAA
     AYIQCQFEDL NKRKDTKEIY THFTCATDTK NVQFVFDAVT DVIIKNNLKD CGLF
//
